301246.SZ
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
SZSE · C 制造业 · CN
CNY 20.84
−1.28%Margins
Gross margin
24.1%
EBITDA margin
16.4%
EBIT margin
14.9%
Net margin
11.5%
FCF margin
-12.7%
5.5%
Return on equity
4.1%
Return on assets
6.5%
Return on invested capital
0.36x
Asset turnover
-CNY 71.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026